Metformin is a common drug prescribed for patients with Type 2 patients to lower their blood sugar. It is a FDA approved drug since 1995 and is used by about 20 million…
Category: Lung Cancer News
FDA Approves New Drug for Lung Cancer
Lung cancer is one of the leading causes behind cancer related deaths. Various studies and research works are going on to help lung cancer patients to get cure from this disease. Time-to-time,…
Simple Urine Test for Early Detection of Lung Cancer
Scientists have developed a world-first urine test to indicate the possible signs of lung cancer. This urine test has been developed by Cambridge scientists and is said to be first of its…
Lung Cancer Screening : What to Expect
According to National Cancer Institute of US, lung cancer is the most common cause of cancer deaths in the country. One of the vital factors that contribute towards its survival is early…
Tarlatamab for Small Cell Lung Cancer
Lung cancer is the second most form of cancers and remains the leading cause of cancer deaths. A variety of new treatments are helping to bring down the number of deaths from…
UK Study Shows Ethic And Social Inequalities In Diagnosis Of Lung Cancer
The most comprehensive UK study ever conducted of lung cancer diagnosis has revealed significant disparities among ethnic groups. It has found evidences that people living in most deprived areas were diagnosed with…
Study: Physical Tests Vital in Treating Metastatic Lung Cancer
According to a new study from the researchers in Brazil and the United States, simple physical tests like sitting down, standing up and walking can significantly aid physicians in managing treatments for…
FDA Approves Optune Luna for Metastatic NSCLC
U.S. based FDA has approved Optune Lua for concurrent use with PD-1/PD-L1 inhibitors for treatment of patients with metastatic non-small cell lung cancer and whose disease has progressed on or after platinum-based…